西藏药业

600211 Public

SSE exchange • Created Jan 14, 2026

Financial reports

Public filings from SEC EDGAR and company websites.

AI reports

Completed valuation analysis reports.

Last cutoff

Dec 31, 2024

Most recent financial reporting period.

Ticker price

RMB 41.63

Updated Mar 9, 2026

Fair value

??? (Subscribe to view)

Updated Jan 14, 2026

AI-generated reports

Track completed analysis reports.

Report name	Report date	Language	Fair value
2025年估值分析	Dec 31, 2024	中文	??? (Subscribe to view)

Editorial coverage tied to this company.

Public filings from SEC EDGAR and company websites.

Report name	Report date	Language
20241231_zh.pdf	Dec 31, 2024	ZH